Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.
The semen plasma virus load is measured to ensure the safety of sperm processing during medically assisted procreation (MAP) for couples with a human immunodeficiency virus type 1 (HIV-1)-infected man. A practical, automated protocol using the COBAS Ampliprep CAP/CTM kit in the COBAS TaqMan96 system was developed to measure the HIV-1 load in semen plasma samples. HIV-1 was detected in 13.4% of the semen samples processed at our MAP center. Of the eight patients having a detectable semen HIV-1 load, five had no detectable virus in their blood plasma. This highlights the residual risk of HIV-1 transmission during unprotected intercourse and raises the question of the possible consequences of ineffective highly active antiretroviral therapy in the genital tract.
Pasquier
Christophe
C
Service de Virologie, CHU de Toulouse, Institut Fédératif de Biologie, TSA40031, 330 avenue de Grande Bretagne, Toulouse F-31059, France. pasquier.c@chu-toulouse.fr
Sauné
Karine
K
Raymond
Stéphanie
S
Moinard
Nathalie
N
Daudin
Myriam
M
Bujan
Louis
L
Izopet
Jacques
J
D023241:Antiretroviral Therapy, Highly Active; D001769:Blood / Q000821:virology; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D021141:Nucleic Acid Amplification Techniques / Q000379:methods; D012661:Semen / Q000821:virology*; D019562:Viral Load